Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
OS Therapies’ OST-HER2 Immunotherapy for Osteosarcoma Featured in Upcoming Movie Shelter Me: The Cancer Pioneers
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Jersey Mike's Donates All Sales to Local Charities Tomorrow
-
AI Powers Record 2024 Revenue, but Automotive and Industrial Struggles Linger Says Omdia
-
E-Cite Partners With OEM Contract Manufacturer "The AIH Group" to Spearhead Production of E-Cites Vehicles - Global Footprint of Engineering and Assembly Established
-
Jayud Global Logistics Launches Exclusive Chartered Air Cargo Service Between Fuzhou and Jakarta
-
The Refurb Company USA Launches to Bring Industry-Leading Refurbishment Solutions to North America
-
Wolters Kluwer CCH® Tagetik Expert Solution has leading position in BARC Financial Consolidation & Group Accounting Survey
-
Big Tree Closes Transaction for Sale of Biodiversity Business Plan to NANAVERSE Inc.
-
Premium Appoints Former Blackrock Senior Executive Chris Leavy to Board of Directors
-
WebFEAT Complete Launches Digital Audit to Help Businesses Improve Online Visibility
-
New member of Jyske Bank’s Group Executive Board
-
Cognition Therapeutics to Report Biomarker Results from Phase 2 SHINE Study in Mild-to-Moderate Alzheimer’s Disease in Podium Presentation at AD/PD 2025
-
E-Cite Partners With OEM Contract Manufacturer "The AIH Group" to Spearhead Production of E-Cites Vehicles - Global Footprint of Engineering and Assembly Established
-
FTI Technology Launches IQ.AI for Review to Accelerate High-Stakes Discovery and Investigations
-
ZCorum Offers an Immediate Service Activation Solution for Operators with DZS Fiber Equipment
-
Quaker Houghton Expands Advanced Solutions Portfolio Through its Acquisition of Dipsol Chemicals
-
HPQ Fumed Silica Reactor Pilot Plant Achieves First Important Morphological Validation Milestone
-
RXNT Launches Upgraded Insurance Payments Platform to Streamline Healthcare Revenue Cycles
-
EISAI TO PRESENT LECANEMAB REAL-WORLD EXPERIENCE DATA AND FINDINGS FROM NEUROLOGY PORTFOLIO AT THE AMERICAN ACADEMY OF NEUROLOGY (AAN) ANNUAL MEETING
-
CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
Palatin's Oral MC4R Agonist PL7737 Receives FDA Orphan Drug Designation for Obesity Due to Leptin Receptor Deficiency
-
FMC Corporation named 2025 CIO 100 award winner for Arc™ farm intelligence
-
Inflammatix Ships TriVerity™ Test Cartridges and Myrna™ Instruments to the U.S. Military
-
Soligenix Announces Publication Demonstrating CiVax™ Booster Induces Rapid Broad Protection Against COVID-19 Variants
-
Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases
-
Core & Main Announces Fiscal 2024 Fourth Quarter and Full-Year Results
-
Redwire Awarded NASA Contract to Expand Pharmaceutical Drug Development in Space for Future Commercialization
-
Kezar Life Sciences Announces Positive Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis (AIH) and Reports Fourth Quarter
-
Padres to Add 20 EV Chargers to Parkade for 2025 Season in Partnership with XLR8 America
-
Bowman Secures $3.8M in Water Resource Contracts
-
EG America Selects PAR Technology to Transform Customer Loyalty with their New SmartRewards Program
-
FDA Grants Priority Review for Biologics License Application (BLA) and EMA Accepts Marketing Authorisation Application (MAA) for Apitegromab as a Treatment for Spinal Muscular Atrophy
-
SER Group Doubles Down on SAP Document Automation Expertise With Acquisition of AFI Solutions
-
AGNICO EAGLE PROVIDES NOTICE OF RELEASE OF FIRST QUARTER 2025 RESULTS, CONFERENCE CALL AND ANNUAL MEETING
-
Kobo Resources Provides Corporate Update and Outlines 2025 Exploration Plans
-
XCharge North America Partners With Hypercharge to Deploy First GridLink Chargers Across Canada
-
Neuron23 Announces Publication in PNAS Highlighting the Important Role of TYK2 in Neuroimmunology
-
Relmada Therapeutics Licenses Phase 2 Bladder Cancer Candidate, NDV-01, from Trigone Pharma, Ltd.
-
Vecima to Highlight AI-Driven Content Quality, Efficiency, and Performance at NAB Show 2025
-
BTCC Exchange Enhances VIP Program to Empower High-Volume Traders Worldwide
-
Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR
-
Cycurion Announces Launch of Cyber Shield, a Comprehensive Managed Security Services Platform
-
ADN Telecom signs multi-year Telesat Lightspeed partnership agreement
-
Enable Injections Announces Regulatory CE Mark Approval in Europe for enFuse Technology
-
Credit Union 1 Selects nCino to Power True Omnichannel Experience for Members
-
Creative Realities Completes SOC 2 Type 1 Compliance Audit Process
-
SysAid Announces General Availability of Agentic AI Platform with AI Agents for ITSM -- Easy to Use, Secure, and with Enterprise-Grade Capabilities
-
Shell plc files Form 20-F with SEC
-
Core & Main Announces Leadership Transition

